Adult obesity prevalence: female (age-standardized, %) vs Oncology novel active substance (NAS) launches (cumulative) in China
Adult obesity prevalence: female (age-standardized, %) (annual) and Oncology novel active substance (NAS) launches (cumulative) (multi-month) in China. They are published at different intervals, so each is drawn on its own rather than matched period by period.
Change the pair
Compare different indicators
The series
Over time
China. Adult obesity prevalence: female (age-standardized, %) is published as annual figures and oncology novel active substance (NAS) launches (cumulative) as multi-month ones, so they are drawn on separate charts, and no period is matched between them. Read each on its own.
Adult obesity prevalence: female (age-standardized, %)
Unit: % · 26 observations
Estimates are listed as such in the table below No figure published for these periods
View the underlying data
| Period | Type | Value |
|---|---|---|
| 1990 | Estimate | 1.86% |
| 1991 | Estimate | 1.93% |
| 1993 | Estimate | 2.09% |
| 1994 | Estimate | 2.17% |
| 1995 | Estimate | 2.26% |
| 1997 | Estimate | 2.43% |
| 1998 | Estimate | 2.52% |
| 1999 | Estimate | 2.62% |
| 2000 | Estimate | 2.72% |
| 2001 | Estimate | 2.83% |
| 2002 | Estimate | 2.94% |
| 2003 | Estimate | 3.05% |
| 2004 | Estimate | 3.18% |
| 2006 | Estimate | 3.47% |
| 2007 | Estimate | 3.63% |
| 2008 | Estimate | 3.81% |
| 2009 | Estimate | 4.01% |
| 2010 | Estimate | 4.21% |
| 2011 | Estimate | 4.43% |
| 2014 | Estimate | 5.14% |
| 2015 | Estimate | 5.4% |
| 2016 | Estimate | 5.68% |
| 2017 | Estimate | 5.97% |
| 2018 | Estimate | 6.27% |
| 2019 | Estimate | 6.58% |
| 2022 | Estimate | 7.63% |
Oncology novel active substance (NAS) launches (cumulative)
Unit: count · 2 observations
Shared periods
Side by side
No period lines up: adult obesity prevalence: female (age-standardized, %) is annual and oncology novel active substance (NAS) launches (cumulative) is multi-month. A month and a year are not the same measurement window, so no row pairs them.
Provenance
Where these numbers come from
Adult obesity prevalence: female (age-standardized, %)
Percentage of female adults aged 18 and older with a body mass index (BMI) of 30 kg/m² or higher, age-standardized estimate.
26 observations charted in China · source organisations: WHO
Oncology novel active substance (NAS) launches (cumulative)
Total number of oncology novel active substances launched over a stated multi-year period.
2 observations charted in China · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring